Background: Atrial fibrillation (AF) is associated with activation of the renin-angiotensin system (RAS) in the atria. Angiotensin-(1-7) [Ang-(1-7)] is a biologically active component of the RAS, it not only counterbalances the actions of angiotensin II (Ang II) but also is a potential inhibitor of angiotensin-converting enzyme (ACE). The purpose of this study was to investigate the effects of the ACE inhibitor enalapril, the angiotensin-receptor blocker (ARB) irbesartan, and Ang-(1-7) on the chronic atrial ionic remodeling.
Methods: Thirty dogs were assigned to sham, paced, paced + enalapril, paced + irbesartan or paced + Ang-(1-7) group, 6 dogs in each group. Rapid atrial pacing at 500 beats per minute was maintained for 14 days, but dogs in sham group were instrumented without pacing. During the pacing, enalapril (2 mg · Kg(-1) · d(-1)) and irbesartan (60 mg · Kg(-1) · d(-1)) were given orally and Ang-(1-7) (6 μg · Kg(-1) · h(-1)) was given intravenously. Whole-cell patch-clamp technique was used to record atrial ionic currents and action potential duration (APD). And RT-PCR was applied to assess atrial mRNA expression of I(TO) Kv4.3 and I(CaL)α1C subunits.
Results: Compared with sham, rapid pacing shortened APD90 (P < 0.05) of atrial myocytes, and decreased APD90 rate adaptation (P<0.05). APD90 changes were prevented by irbesartan and Ang-(1-7), but not enalapril. In atria from paced group, the densities and gene expression of I(TO) and I(CaL) were reduced (P < 0.01 vs. sham). Enalapril increased the density and gene expression of I(TO) compared with sham (P < 0.01), Ang-(1-7) prevented the decrease of I(TO) and I(CaL) (P < 0.05 vs. control) and Kv4.3 mRNA expression (P < 0.01 vs. control). Irbesartan had no effect on I(TO) and I(CaL) densities or mRNA expression.
Conclusions: These results suggest that enalapril, irbesartan, and Ang-(1-7) have differing influences on atrial tachycardia-induced atrial ionic remodeling.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ijcard.2009.07.015 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Preparation of Human Atrial Trabeculae for Ex Vivo Analysis of Human Myocardial Function.
Methods Mol Biol
December 2024
Department of Physiology, HeartOtago, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.
Human myocardial function can be investigated in the laboratory using human atrial trabeculae. These multicellular preparations provide a translatable model for assessing the ex vivo contractility, electrophysiology, and ionic and metabolic underpinnings of human cardiac muscle. Here, we detail the materials and methods required to determine the baseline function of a human atrial trabecula, from dissection to stimulation.
View Article and Find Full Text PDFAssociation between Atrial Fibrillation and Risk of Alzheimer's Disease and Vascular Dementia: A Systematic Review and Meta-analysis.
Ann Indian Acad Neurol
November 2024
Department of Cardiology, Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Background And Objectives: Recent research suggests that atrial fibrillation (AF) may influence the risk of developing Alzheimer's disease (AD) and vascular dementia (VaD). However, existing studies have provided inconsistent results, with some showing a significant association between AF and the risk of AD and VaD, while others do not. The objective of this study is to conduct a meta-analysis to investigate the association between AF and the risk of AD and VaD.
View Article and Find Full Text PDFProspective in silico trials identify combined SK and KP channel block as an effective strategy for atrial fibrillation cardioversion.
J Physiol
November 2024
Department of Computer Science, University of Oxford, Oxford, UK.
Virtual evaluation of medical therapy through human-based modelling and simulation can accelerate and augment clinical investigations. Treatment of the most common cardiac arrhythmia, atrial fibrillation (AF), requires novel approaches. This study prospectively evaluates and mechanistically explains three novel pharmacological therapies for AF through in silico trials, including single and combined SK and KP channel block.
View Article and Find Full Text PDFPlasma metabolomic characteristics of atrial fibrillation patients with spontaneous echo contrast.
BMC Cardiovasc Disord
November 2024
Tianjin Key laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, No. 23 Pingjiang Road, Hexi District, Tianjin, 300211, China.
Article Synopsis
- Patients with atrial fibrillation (AF) displaying spontaneous echo contrast (SEC) show signs of being in a prethrombic state, which can lead to thrombus formation.
- The study aimed to uncover the specific metabolic characteristics associated with SEC by analyzing metabolic pathways and identifying differential metabolites between SEC and non-SEC states.
- Findings revealed significant differences in metabolic patterns, with SEC patients showing a higher level of metabolic dysregulation in atrial plasma, which could help inform future therapeutic interventions and research directions for preventing thrombosis in AF patients.
Arrhythmogenic atrial remodeling during pregnancy in mice.
Heart Rhythm
November 2024
Faculty of Pharmacy, Université de Montréal, Montréal, Quebec, Canada; Research Center, Montreal Heart Institute, Montréal, Quebec, Canada. Electronic address:
Background: Pregnancy is associated with greater vulnerability to supraventricular tachyarrhythmias.
Objective: As the underlying mechanisms remain to be elucidated, we investigated whether pregnancy induces atrial remodeling that might contribute to this.
Methods: Atrial electrophysiological and contractile properties were examined in nonpregnant and pregnant (P) mice.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!